These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 21033670)

  • 1. Design, synthesis, and DNA-binding of N-alkyl(anilino)quinazoline derivatives.
    Garofalo A; Goossens L; Baldeyrou B; Lemoine A; Ravez S; Six P; David-Cordonnier MH; Bonte JP; Depreux P; Lansiaux A; Goossens JF
    J Med Chem; 2010 Nov; 53(22):8089-103. PubMed ID: 21033670
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acenaphtho[1,2-b]pyrrole derivatives as new family of intercalators: various DNA binding geometry and interesting antitumor capacity.
    Zhang Z; Yang Y; Zhang D; Wang Y; Qian X; Liu F
    Bioorg Med Chem; 2006 Oct; 14(20):6962-70. PubMed ID: 16828559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA binding to guide the development of tetrahydroindeno[1,2-b]pyrido[4,3,2-de]quinoline derivatives as cytotoxic agents.
    Catoen-Chackal S; Facompré M; Houssin R; Pommery N; Goossens JF; Colson P; Bailly C; Hénichart JP
    J Med Chem; 2004 Jul; 47(14):3665-73. PubMed ID: 15214793
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthesis and evaluation of 9-anilinothiazolo[5,4-b]quinoline derivatives as potential antitumorals.
    Rodríguez-Loaiza P; Quintero A; Rodríguez-Sotres R; Solano JD; Lira-Rocha A
    Eur J Med Chem; 2004 Jan; 39(1):5-10. PubMed ID: 14987829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Substitution at the F-ring N-imide of the indolocarbazole antitumor drug NB-506 increases the cytotoxicity, DNA binding, and topoisomerase I inhibition activities.
    Bailly C; Qu X; Chaires JB; Colson P; Houssier C; Ohkubo M; Nishimura S; Yoshinari T
    J Med Chem; 1999 Jul; 42(15):2927-35. PubMed ID: 10425102
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benzoquinazoline derivatives as new agents affecting DNA processing.
    Marzaro G; Dalla Via L; Toninello A; Guiotto A; Chilin A
    Bioorg Med Chem; 2011 Feb; 19(3):1197-204. PubMed ID: 21216603
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design and synthesis of 4-amino-2-phenylquinazolines as novel topoisomerase I inhibitors with molecular modeling.
    Le TN; Yang SH; Khadka DB; Van HT; Cho SH; Kwon Y; Lee ES; Lee KT; Cho WJ
    Bioorg Med Chem; 2011 Jul; 19(14):4399-404. PubMed ID: 21684168
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis and biological evaluation of substituted 6-alkynyl-4-anilinoquinazoline derivatives as potent EGFR inhibitors.
    Liu LT; Yuan TT; Liu HH; Chen SF; Wu YT
    Bioorg Med Chem Lett; 2007 Nov; 17(22):6373-7. PubMed ID: 17889528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel DNA intercalators without basic side chains as efficient antitumor agents: design, synthesis and evaluation of benzo-[c,d]-indol-malononitrile derivatives.
    Li X; Wang Q; Qing Y; Lin Y; Zhang Y; Qian X; Cui J
    Bioorg Med Chem; 2010 May; 18(9):3279-84. PubMed ID: 20385497
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro anticancer activity and evaluation of DNA duplex binding affinity of phenyl-substituted indoloquinolines.
    Riechert-Krause F; Eick A; Grünert R; Bednarski PJ; Weisz K
    Bioorg Med Chem Lett; 2011 Apr; 21(8):2380-3. PubMed ID: 21414783
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement of EGFR tyrosine kinase inhibition by C-C multiple bonds-containing anilinoquinazolines.
    Ban HS; Tanaka Y; Nabeyama W; Hatori M; Nakamura H
    Bioorg Med Chem; 2010 Jan; 18(2):870-9. PubMed ID: 19969465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of mono- and bisdihydrodipyridopyrazines and assessment of their DNA binding and cytotoxic properties.
    Blanchard S; Rodriguez I; Tardy C; Baldeyrou B; Bailly C; Colson P; Houssier C; Léonce S; Kraus-Berthier L; Pfeiffer B; Renard P; Pierré A; Caubère P; Guillaumet G
    J Med Chem; 2004 Feb; 47(4):978-87. PubMed ID: 14761199
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, synthesis, and biological properties of new bis(acridine-4-carboxamides) as anticancer agents.
    Antonini I; Polucci P; Magnano A; Gatto B; Palumbo M; Menta E; Pescalli N; Martelli S
    J Med Chem; 2003 Jul; 46(14):3109-15. PubMed ID: 12825949
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synthesis and cytotoxic activity of a new potential DNA bisintercalator: 1,4-Bis{3-[N-(4-chlorobenzo[g]phthalazin-1-yl)aminopropyl]}piperazine.
    Galisteo J; Navarro P; Campayo L; Yunta MJ; Gómez-Contreras F; Villa-Pulgarin JA; Sierra BG; Mollinedo F; Gonzalez J; Garcia-España E
    Bioorg Med Chem; 2010 Jul; 18(14):5301-9. PubMed ID: 20538470
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery of novel 4-anilinoquinazoline derivatives as potent inhibitors of epidermal growth factor receptor with antitumor activity.
    Xu YY; Li SN; Yu GJ; Hu QH; Li HQ
    Bioorg Med Chem; 2013 Oct; 21(19):6084-91. PubMed ID: 23962660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 1-[(omega-aminoalkyl)amino]-4-[N-(omega-aminoalkyl)carbamoyl]-9-oxo-9, 10-dihydroacridines as intercalating cytotoxic agents: synthesis, DNA binding, and biological evaluation.
    Antonini I; Polucci P; Jenkins TC; Kelland LR; Menta E; Pescalli N; Stefanska B; Mazerski J; Martelli S
    J Med Chem; 1997 Nov; 40(23):3749-55. PubMed ID: 9371240
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis, antitumor evaluation and docking study of novel 4-anilinoquinazoline derivatives as potential epidermal growth factor receptor (EGFR) inhibitors.
    Rao GW; Xu GJ; Wang J; Jiang XL; Li HB
    ChemMedChem; 2013 Jun; 8(6):928-33. PubMed ID: 23640754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 3,6-bis(3-alkylguanidino)acridines as DNA-intercalating antitumor agents.
    Plsikova J; Janovec L; Koval J; Ungvarsky J; Mikes J; Jendzelovsky R; Fedorocko P; Imrich J; Kristian P; Kasparkova J; Brabec V; Kozurkova M
    Eur J Med Chem; 2012 Nov; 57():283-95. PubMed ID: 23072739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and biological activity of novel inhibitors of topoisomerase I: 2-aryl-substituted 2-bis-1H-benzimidazoles.
    Singh M; Tandon V
    Eur J Med Chem; 2011 Feb; 46(2):659-69. PubMed ID: 21186067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 5-Non-amino aromatic substituted naphthalimides as potential antitumor agents: Synthesis via Suzuki reaction, antiproliferative activity, and DNA-binding behavior.
    Xie L; Cui J; Qian X; Xu Y; Liu J; Xu R
    Bioorg Med Chem; 2011 Jan; 19(2):961-7. PubMed ID: 21208805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.